Welcome to the e-CCO Library!

P078: Proteomics and Lipidomics Analysis Revealed Alterations of Complement Activation and Lipid Metabolism in peripheral blood mononuclear cells of Inflammatory Bowel Disease Patients
Year: 2021
Source: ECCO'21 Virtual
Authors: Notararigo, S.(1);Bravo, S.(1);Martin-Pastor, M.(2);Baston-Rey, I.(3);Quiroga-Castiñeira, A.(3);Dominguez-Munoz, J.E.(3);Domínguez Medina, E.(1);Barreiro-de Acosta, M.(3);
Created: Wednesday, 2 June 2021, 4:12 PM
P078: Vedolizumab Treatment of ex-vivo Human Ulcerative Colitis (UC) Explants Results in Altered Inflammatory Protein Secretion Profiles
Year: 2022
Source: ECCO'22
Authors: Corcoran, R.(1);O'Connell, F.(2);O'Sullivan, J.(2);Kevans, D.(1);
Created: Friday, 11 February 2022, 3:52 PM
P078: Vitamin D concentrations affect the composition of T-lymphocyte subsets and proinflammatory cytokine production in patients with inflammatory bowel disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

J. Schardey1*, A.-M. Globig1,2, C. Janssen1, M. Hofmann1, P. Manegold3, R. Thimme1, P. Hasselblatt1

Created: Thursday, 21 February 2019, 9:14 AM
P078: Walnut extract ameliorates acute and chronic colitis in murine models of colitis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

S.-J. Koh*, K. L. Lee, J.W. Kim, B. G. Kim, Y. J. Jung

Created: Friday, 22 February 2019, 9:49 AM
P079 High-dimensional mass cytometry after local MSC treatment in patients with refractory proctitis shows an effect on the myeloid compartment: preliminary data
Year: 2020
Source:

ECCO'20 Vienna

Authors:

L. Ouboter Drs.1,2, M.C. Barnhoorn1, L.J.A.C. Hawinkels1, M. van Pel2, J.J. Zwaginga2, H.W. Verspaget1, F. Koning2, M.F. Pascutti2, A.E. van der Meulen-de Jong1

Created: Thursday, 30 January 2020, 10:12 AM
P079: Association of gut microbiota with mucosal inflammation in ulcerative colitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Quraishi M.N.*1,2, Rossiter A.3, Chung B.4,5, Beaumont M.6, Liaskou E.4, Horniblow R.1, Beggs A.1, Withers D.7, Ghosh S.2,8, Tselepis C.1, Hirschfield G.4, Iqbal T.H.1,2

Created: Wednesday, 20 February 2019, 10:36 AM
P079: Attenuation of inflammation and histologic production-dependent improvement by engineered high acetate producing Saccharomyces boulardii in DSS-induced colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Deleu, S.(1)*;Trindade de Carvalho , B.(2);Jacobs, I.(3);Arnauts, K.(1);Deprez, L.(4);Vissers , E.(1);Lenfant, M.(1);De Hertogh, G.(5);Huys, G.(6);Thevelein, J.(2);Raes, J.(6);Vermeire, S.(7);
Created: Friday, 14 July 2023, 10:48 AM
P079: Increased faecal proteolytic activity in pouchitis patients mediates epithelial barrier disruption through activation of protease-activated receptor-2
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Hoffman*1, I. M. Carrol2, H. Tulchinski3,4, I. Borovok5, I. Dotan6

Created: Friday, 22 February 2019, 9:41 AM
P079: Perfused intestinal tubules for real-time assessment of drug-induced barrier disruption
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Trietsch1, E. Naumowska1*, D. Kurek1, M. Setyawati1, M. Vormann1, K. Wilschut1, H. Lanz1, A. Nicolas1, C. Ping Ng1, J. Joore1, S. Kustermann2, A. Roth2, T. Hankemeier3, A. Moisan2, P. Vulto1

Created: Thursday, 21 February 2019, 9:14 AM
P079: The expression of some circulating micro RNAs and serum Vitamin D levels in IBD patients
Year: 2022
Source: ECCO'22
Authors: Atanassova, A.(1);GeorgievaPhD, A.C.(1);
Created: Friday, 11 February 2022, 3:52 PM
P079: Trehalose ameliorates colitis by increasing mucosal autophagy and M2 polarisation
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

J. Cosin-Roger*1, D. Ortiz-Masia1, D. C. Macias-Ceja2, P. Salvador1, L. Gisbert-Ferrandiz1, C. Hernandez2, S. Calatayud1, M. D. Barrachina1

Created: Friday, 22 February 2019, 9:49 AM
P079: Valproic acid increases MiR449a expression in intestinal mucosa from patients with inflammatory bowel disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Felice, C.(1);Lewis, A.(2);Armuzzi, A.(3);Lindsay, J.O.(4);Silver, A.(2);
Created: Wednesday, 2 June 2021, 4:12 PM
P080 Therapeutical effect of urine-derived stem cells on DSS-induced chronic model of mice
Year: 2020
Source:

ECCO'20 Vienna

Authors:

X.R. Wu, C. Zhou, H.S. Liu, L. Xuan-hui, T. Hu, X.B. Zheng, Z.X. Liang, X.J. Wu, X. Gao, X.S. He, J. Ke, Y.F. Chen, X.W. He, J.C. Hu, Y. Zou, P. Lan

Created: Thursday, 30 January 2020, 10:12 AM
P080: ADS024 attenuates weight loss and decreases disease activity in DSS-induced colitis
Year: 2022
Source: ECCO'22
Authors: Chesnel, L.(1);Acton, S.(1);
Created: Friday, 11 February 2022, 3:52 PM
P080: Burden of Disease and Cost of Illness of Inflammatory Bowel Diseases in Portugal
Year: 2021
Source: ECCO'21 Virtual
Authors: Magro, F.(1);Portela, F.(2);Lago, P.(3);Chagas, C.(4);Moreira, F.(5);Pereira, F.(5);Rodrigues, B.(6);Pedrosa, H.(5);Correia, L.(7);
Created: Wednesday, 2 June 2021, 4:12 PM
P080: Histopathologic evaluation and lymphocyte subpopulations of the duodenal mucosa of Crohn’s disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Martin-Cardona1*, Y. Zabana Abdo1,2, M. Aceituno Quintanilla1,2, A. Carrasco García2,3, C. Loras Alastruey1,2, X. Andujar Murcia1,2, E. Tristán Lopez E3, O. Benítez Leiva O1, C. Ferrer Cassado4, F. Fernández-Bañares F1,2, M. Esteve Comas1,2

Created: Thursday, 21 February 2019, 9:14 AM
P080: IL-10 induction properties of the TLR-9 agonist cobitolimod – a candidate for treatment of active ulcerative colitis in late stage of clinical development
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Admyre C.1, Zargari A.1, Atreya R.2, Knittel T.*1

Created: Wednesday, 20 February 2019, 10:36 AM
P080: Modulation of T-cell glycosylation and the control of intestinal inflammation
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

A. M. Dias*1, 2, A. Correia3, M. Pereira1, C. R. Almeida4, M. Lima5, 6, R. Marcos-Pinto2, 7, 8, M. Vilanova2, 3, C. A. Reis1, 2, 9, P. Lago8, 
S. S. Pinho1, 2

Created: Friday, 22 February 2019, 9:49 AM
P080: Mucosal clock and inflammation regulatory genes are disrupted in treatment naïve pediatric patients with ulcerative colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Labes, S.(1);Tabach, Y.(1);Matar, M.(2,3);Shamir, R.(2,3);Shouval, D.S.(2,3);Froy, O.(4);Weintraub, Y.(2,3)*;
Created: Friday, 14 July 2023, 10:48 AM
P080: Thioguanine nucleotide cut-off levels to predict leucopoenia should be considered differently based on NUDT15 R139C genotypes in Chinese Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

X. Zhu1, K. Chao2, H. Zheng1, P. Hu2, M. Huang1, X. Gao*2, X. Wang1

Created: Friday, 22 February 2019, 9:41 AM